JessicaJayneLiegelMD

PubMed

• Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
  Myrna R. Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia Rachel Pyzer, Eleni Anastasiadou, Anna Sergeeva, Adam Ephraim, Abigail Washington, Shira Or...> ;British Journal of Haematology. 2019 May 1
• Use of sorafenib for post-transplant relapse in FLT3/ITD-positive acute myelogenous leukemia: maturation induction and cytotoxic effect
  Jessica Liegel, Elizabeth L. Courville, Zohar Sachs, Celalettin Ustun> ;Haematologica. 2014 Jul 11

Abstracts/Posters

• CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model
  Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
  Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematologi...
  Jessica Liegel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/2019

Lectures

• T Cells Educated By DC/AML Fusions in the Context of 4-1BB Costimulation As a Potent Strategy for Adoptive Cellular Therapy 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Transcriptome Sequencing Demonstrates Unique Signature Associated with Durable Clinical Response to DC/AML Fusion Vaccine 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018